• Company
    • Leadership
      • Management Team
      • Board of Directors
    • Partners
      • Research Partners
      • Investors
    • Careers
      • Open Positions
  • Approach
    • Redefining Disease
      • Precision Medicine
      • Genetically-Defined AMD
    • Understanding Ocular Disease
      • CLARITY Studies
    • Therapeutic Modalities
      • Therapeutic Approach
      • Recombinant Proteins
      • Gene Therapy
      • Monoclonal Antibodies
  • Pipeline
    • Programs
      • Complement Factor H
    • Scientific Advisors
      • Founders
      • Advisory Board
  • Investors & Media
    • News
    • Events
    • Presentations
  • Contact
Gemini Therapeutics Logo
  • Company
    • Leadership
      • Management Team
      • Board of Directors
    • Partners
      • Research Partners
      • Investors
    • Careers
      • Open Positions
  • Approach
    • Redefining Disease
      • Precision Medicine
      • Genetically-Defined AMD
    • Understanding Ocular Disease
      • CLARITY Studies
    • Therapeutic Modalities
      • Therapeutic Approach
      • Recombinant Proteins
      • Gene Therapy
      • Monoclonal Antibodies
  • Pipeline
    • Programs
      • Complement Factor H
    • Scientific Advisors
      • Founders
      • Advisory Board
  • Investors & Media
    • News
    • Events
    • Presentations
  • Contact
Home Contact

Contact

Gemini Therapeutics
300 One Kendall Square, 3rd Floor
Cambridge, MA 02139

General Inquiries

info@geminitherapeutics.com

Investors and Media

Argot Partners
gemini@argotpartners.com
212.600.1902

Business Development

bizdev@geminitherapeutics.com

Approach
We See Disease Differently
Gemini Therapeutics Logo
  • Contact
  • Privacy Policy
  • Follow:
© 2020 Gemini Therapeutics